查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014992

醫用影像模體市場：依產品類型、材料、應用和最終用戶分類－2026-2032年全球市場預測

Medical Imaging Phantoms Market by Product Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療影像模型市場價值將達到 1.6322 億美元，到 2026 年將成長至 1.7853 億美元，到 2032 年將達到 2.8666 億美元，複合年成長率為 8.37%。

主要市場統計數據
基準年 2025 1.6322億美元
預計年份：2026年 1.7853億美元
預測年份 2032 2.8666億美元
複合年成長率 (%) 8.37%

本文全面概述了醫學影像模型的基礎性內容，重點介紹了技術進步、臨床作用、檢驗要求以及相關人員。

醫學影像模型是連結技術開發、臨床檢驗和操作人員培訓的關鍵工具，貫穿整個診斷和介入工作流程。這些工程結構能夠模擬解剖結構、組織特性和放射學反應，為儀器校準、成像方案檢驗和多學科團隊訓練提供可重複且檢驗的條件。隨著成像方式的解析度、速度和功能不斷提升，模型的作用也從簡單的幾何目標擴展到反映現代臨床實踐需求的複雜多模態測試對象。

對正在重塑幻影製造業的重大變革進行詳細分析，包括積層製造、人工智慧、檢驗、材料科學和監管融合。

多項變革正積極重塑醫學影像模型領域，改變技術發展方向和商業性重點。積層製造技術能夠快速迭代製造以往無法實現的複雜形狀和內部結構，使開發人員能夠更快地製作原型並檢驗特定成像方式的功能。同時，先進材料，特別是那些能夠更真實地再現介電、聲學或輻射密度特性的材料，使模型能夠展現混合成像平台所需的多物理場特性。

檢驗美國2025年後的關稅措施對整個虛擬生態系統的供應鏈、籌資策略和製造本地化決策的累積影響。

美國2025年實施的關稅措施立即給成像模型製造商及其買家的全球供應鏈和籌資策略帶來了壓力。某些進口零件和原料關稅的提高迫使企業重新評估供應商所在地，考慮近岸外包方案，並加快替代供應商的認證流程。實際上，由於買家需要進行額外的合規性檢查，並了解現有採購合約對總到岸成本的影響，因此採購週期暫時延長。

詳細的細分分析揭示了產品類型、材料科學、應用重點和最終用戶行為如何相互交織，從而決定工程選擇、採購動態和服務模式。

細分市場分析揭示了產品類型差異化、材料選擇、應用重點和最終用戶特徵如何影響開發優先順序和購買行為。就產品類型而言，電腦斷層掃描 (CT) 模體優先考慮高對比度病灶模擬和衰減精度，而磁振造影 (MRI) 模體則強調弛豫參數的保真度和磁化率控制。核子醫學影像模體需要精確的放射性分佈和衰減特性，而正子斷層掃描 (PET) 模體必須考慮同時發生的事件速率和正子射程效應。超音波模體需要可重複的聲電阻和反向散射特性，而 X光模體則需要在幾何保真度和輻射密度校準要求之間取得平衡。因此，每種產品類型都有其獨特的權衡取捨和檢驗方案，製造商必須加以解決。

透過對美洲、歐洲、中東和非洲以及亞太地區的戰略區域洞察，重點在於採用促進因素、監管重點、製造優勢和採購模式。

區域趨勢對整個人體模型市場的技術應用、監管預期和製造策略都有顯著影響。在美洲，研發中心和完善的臨床基礎設施正在推動對高精度、合規人體模型的需求，這些模型既支援醫療設備檢驗，也支援臨床培訓計畫。在該地區，合規文件、國內供應的連續性和供應商的透明度在採購過程中日益重要，這有利於那些提供認證產品和及時售後服務的製造商。

主要企業洞察，捕捉創新重點、夥伴關係策略、認證和服務差異化，從而推動競爭優勢和長期客戶關係。

在企業層面，一些市場參與企業通用的策略主題正在出現。首先，創新周期日益聚焦於材料工程和製造柔軟性。行業領導企業正投資研發專有複合材料和製造程序，以實現快速客製化，同時確保檢驗的完整性。其次，與臨床中心和醫療設備製造商 (OEM)夥伴關係，能夠加速產品改進，並有助於獲取檢驗數據，從而展現產品在真實環境中的表現。這些合作途徑縮短了從研發到臨床應用的回饋週期。

為產業領導者提供切實可行的建議，以加強供應鏈韌性、加速材料創新、擴大臨床夥伴關係以及擴大以服務為基礎的差異化規模。

產業領導者可在多個領域採取果斷行動，以確保永續成長並降低新興風險。首先，他們應優先考慮供應鏈多元化，通過認證互補區域的多家供應商，並選擇性地投資於關鍵零件的近岸生產能力。這些措施將降低貿易政策變化帶來的風險，同時保持研發的彈性。其次，他們應加快對材料研發和積層製造（AM）能力的投資，以開發高保真度、與成像模式無關的模擬體，並縮短客製化應用的設計週期。

本文檔說明了為確保可靠性和有效性而採用的透明、嚴謹的調查方法，包括初步訪談、技術檢驗、文獻整合、專家評審和三角驗證。

本分析的調查方法結合了定性和技術方法，以確保其嚴謹性和有效性。主要數據來自對臨床醫生、採購負責人、工程經理和材料科學家的結構化訪談，這些訪談提供了對性能預期和運行限制的背景理解。二級資訊來源包括同行評審文獻、標準文件和技術白皮書，這些資料闡明了檢驗實踐和材料性能特徵。

簡明扼要的結論強調了對材料檢驗、供應鏈韌性、監管合規性和臨床夥伴關係進行全面投資的必要性。

總之，醫學影像模型領域正處於一個轉折點，材料創新、製造靈活性和服務主導的差異化將決定其策略走向。模型在醫療設備檢驗、臨床培訓和演算法性能評估中發揮日益重要的作用。相關人員，正在獲得更高的產品採用率。供應鏈的韌性和合規性與卓越的技術相輔相成，構成了規模化生產所需的營運基礎。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫學影像模體市場：依產品類型分類

  • CT模體
  • 磁振造影模型
  • 核子醫學模型
  • PET模型
  • 超音波體模
  • X光模型

第9章 醫用影像模體市場：依材料分類

  • 丙烯酸纖維
  • 環氧樹脂
  • 水凝膠
  • 塑膠
  • 橡皮

第10章 醫學影像模型市場：依應用領域分類

  • 設備測試
  • 品質保證
  • 研究
  • 培訓和教育

第11章 醫學影像模體市場：依最終使用者分類

  • 學術和研究機構
  • 診斷中心
  • 醫院
  • 製藥公司

第12章 醫學影像模體市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫學影像模市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 醫學影像模體市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療影像模體市場

第16章：中國醫用影像模體市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BARTEC Top Holding GmbH
  • Biodex Medical Systems, Inc.
  • Carville Limited
  • Computerized Imaging Reference Systems（CIRS）, Inc.
  • Dielectric Corporation
  • Gammex, Inc.
  • Gold Standard Phantoms
  • Kyoto Kagaku Co., Ltd.
  • Leeds Test Objects Ltd.
  • Modus Medical Devices Inc.
  • PTW Freiburg GmbH
  • Pure Imaging Phantoms
  • QUART GmbH
  • The Phantom Laboratory, Inc.
  • True Phantom Solutions
Product Code: MRR-0363DFE03664

The Medical Imaging Phantoms Market was valued at USD 163.22 million in 2025 and is projected to grow to USD 178.53 million in 2026, with a CAGR of 8.37%, reaching USD 286.66 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 163.22 million
Estimated Year [2026] USD 178.53 million
Forecast Year [2032] USD 286.66 million
CAGR (%) 8.37%

Comprehensive foundational overview of medical imaging phantoms that clarifies technological evolution clinical roles validation requirements and strategic priorities for stakeholders

Medical imaging phantoms serve as indispensable instruments bridging technology development, clinical validation, and operator training across diagnostic and interventional workflows. These engineered constructs replicate anatomical structures, tissue properties, and radiological responses to provide repeatable, verifiable conditions for calibrating devices, validating imaging protocols, and educating multidisciplinary teams. As imaging modalities evolve in resolution, speed, and functionality, the role of phantoms expands beyond simple geometric targets to complex, multimodal test objects that reflect the demands of contemporary clinical practice.

Within this context, stakeholders ranging from device manufacturers to clinical end users rely on phantoms to reduce risk, accelerate regulatory clearance, and optimize performance at scale. Over the past decade, improvements in materials science and manufacturing techniques have enabled higher-fidelity simulation of tissue heterogeneity, molecular contrast behavior, and acoustic properties. Consequently, phantoms now support deeper integration into research pipelines and routine quality assurance programs. The following analysis synthesizes these dynamics to provide a succinct orientation for leaders seeking to understand immediate priorities, emerging opportunities, and operational considerations in the phantom ecosystem.

Detailed analysis of the major transformative shifts reshaping the phantom landscape including additive manufacturing AI validation materials science and regulatory convergence

Several transformative shifts are actively reshaping the landscape for medical imaging phantoms, altering both technological trajectories and commercial priorities. Additive manufacturing now enables rapid iteration of complex geometries and internal structures that were previously infeasible, and as a result, developers can prototype and validate modality-specific features with greater speed. At the same time, advanced materials-particularly those that better mimic dielectric, acoustic, or radiodensity properties-allow phantoms to exhibit multi-physics behavior required for hybrid imaging platforms.

Concurrently, data-driven approaches influence validation processes; machine learning models used in image reconstruction and interpretation demand diverse, annotated datasets for robust training and performance evaluation. This requirement incentivizes phantoms designed to produce reproducible, quantifiable ground truth across modalities. Regulatory and clinical stakeholders are also converging on standardized test protocols, which increases the value of certified, repeatable phantoms. Finally, supply chain transparency and sustainability considerations now guide procurement decisions, encouraging manufacturers to optimize material sourcing and lifecycle impacts. Taken together, these shifts create a landscape in which innovation, validation rigor, and operational resiliency determine competitive advantage.

Examination of the cumulative effects of United States tariff actions from 2025 on supply chains procurement strategies and manufacturing localization decisions across the phantom ecosystem

The introduction of United States tariff measures in 2025 created immediate pressure on global supply chains and procurement strategies for imaging phantom manufacturers and their purchasers. Elevated duties on certain imported components and raw materials prompted firms to reassess supplier footprints, evaluate nearshoring options, and accelerate qualification processes for alternative vendors. In practice, procurement cycles lengthened temporarily as buyers implemented additional compliance checks and sought to understand the total landed cost implications of existing sourcing arrangements.

In response, manufacturers intensified efforts to localize critical processes, particularly those involving high-precision machining, molding, and materials compounding where tariff exposure was most acute. These adjustments often required investments in domestic capacity or the qualification of secondary suppliers in lower-risk jurisdictions. Importantly, the tariff environment has emphasized contractual flexibility and inventory strategy as tactical levers; organizations that maintain responsive logistics and diversified supplier relationships tend to preserve continuity of supply and protect product development timelines. Moving forward, tariffs serve as a catalyst for more robust supply chain design rather than a permanent shift toward protectionism.

In-depth segmentation synthesis revealing how product type material science application focus and end-user behavior converge to dictate engineering choices procurement dynamics and service models

Segmentation analysis illuminates how product type differentiation, material selection, application focus, and end user characteristics shape development priorities and purchasing behavior. Within product typologies, computed tomography-specific phantoms prioritize high-contrast lesion simulation and attenuation accuracy while magnetic resonance phantoms emphasize relaxation parameter fidelity and susceptibility control. Nuclear imaging phantoms require precise activity distribution and attenuation characteristics, whereas PET phantoms must account for coincident event rates and positron range effects. Ultrasound phantoms demand reproducible acoustic impedance and backscatter properties, and X-ray phantoms balance geometric fidelity with radiodensity calibration needs. Each product type therefore drives unique engineering trade-offs and validation protocols that manufacturers must accommodate.

Material choices further influence performance envelopes and lifecycle characteristics. Acrylic and epoxy systems provide stable, machinable platforms suitable for long-term QA tasks, while hydrogel formulations offer tissue-like softness and frequency-dependent acoustic behavior for ultrasound applications. Plastic composites and elastomeric rubbers enable flexible geometries and repeatable mechanical responses, which can be essential for training and simulation modules. The interplay between material properties and intended application-whether equipment testing, quality assurance, research, or training and education-determines acceptable tolerances, aging characteristics, and maintenance requirements.

Application-driven segmentation highlights distinct value propositions. Equipment testing and quality assurance demand rigorous repeatability and traceable calibration standards, emphasizing long-term stability and certifiable performance. Research applications often need customizable, modular phantoms that permit controlled variation of parameters to support hypothesis-driven studies. Training and education prioritize ergonomic realism, cost-effective reproducibility, and safe handling for repeated use. Finally, end users exhibit differentiated procurement behaviors: academic and research institutes typically value configurability and data access for experimentation, diagnostic centers focus on operational reliability and throughput, hospitals emphasize cross-specialty applicability and regulatory compliance, and pharmaceutical companies require phantoms that support imaging biomarker validation and trial reproducibility. Understanding these intersecting segmentation axes enables targeted product strategies and service models that align with stakeholder-specific priorities.

Strategic regional insights across the Americas Europe Middle East and Africa and Asia-Pacific that highlight adoption drivers regulatory priorities manufacturing strengths and procurement patterns

Regional dynamics exert a profound influence on technology adoption, regulatory expectations, and manufacturing strategy across the phantom landscape. In the Americas, innovation centers and established clinical infrastructures drive demand for high-fidelity, regulatory-aligned phantoms that support both device validation and clinical training programs. Procurement processes in this region increasingly emphasize compliance documentation, domestic supply continuity, and vendor transparency, which benefit manufacturers offering certified products and responsive aftermarket services.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and a strong emphasis on clinical standardization create opportunities for phantoms that support cross-border validation and multi-center studies. European markets often prioritize sustainability and lifecycle reporting, encouraging suppliers to document material provenance and end-of-life pathways. In contrast, the Middle East and Africa present a diverse set of clinical maturity levels and infrastructure needs, where scalable, cost-efficient phantoms tailored to training and basic QA programs find strong demand.

Asia-Pacific combines rapid clinical adoption with substantial manufacturing capability, positioning the region as both a major consumer and producer of phantom technologies. Local capabilities in precision manufacturing and materials processing support regional supply chains, while investments in large-scale imaging networks and research initiatives stimulate demand for advanced, modality-specific phantoms. Regional policy priorities, including emissions reduction and supply chain resilience, increasingly shape procurement frameworks and encourage manufacturers to demonstrate both technical performance and environmental stewardship.

Key company insights capturing innovation priorities partnership strategies certification and service differentiation that drive competitive advantage and long-term customer relationships

Company-level dynamics reveal several recurring strategic themes among market participants. First, innovation cycles increasingly revolve around materials engineering and manufacturing flexibility; leaders invest in proprietary composites and fabrication methods that enable rapid customization while preserving validation integrity. Second, partnerships with clinical centers and device OEMs accelerate product refinement and facilitate access to validation data that demonstrate real-world performance. These collaborative pathways shorten feedback loops between development and clinical acceptance.

Third, services and certification pathways offer meaningful differentiation. Companies that couple products with comprehensive calibration services, technical training programs, and documented validation protocols strengthen customer retention and generate recurring revenue streams. Finally, operational excellence in supply chain management and quality systems-especially in regulated jurisdictions-remains a critical factor. Firms that maintain clear traceability, robust change control, and responsive after-sales support tend to secure long-term contracts with large healthcare systems and multinational research consortia.

Practical actionable recommendations for industry leaders to strengthen supply chain resilience accelerate materials innovation expand clinical partnerships and scale service-based differentiation

Industry leaders can act decisively on several fronts to secure sustainable growth and mitigate emerging risks. First, prioritize diversification of supply chains by qualifying multiple suppliers across complementary geographies and by investing selectively in nearshore capabilities for mission-critical components. Such steps reduce exposure to trade policy volatility while preserving development agility. Second, accelerate investment in materials R&D and additive manufacturing capacity to enable higher-fidelity, modality-agnostic phantoms and to shorten design cycles for bespoke applications.

Third, deepen clinical partnerships to co-develop validation protocols and to embed phantoms into early-stage device testing and training curricula; this approach fosters product-market fit and supports adoption. Fourth, enhance service offerings by bundling technical training, calibration, and data packages that demonstrably reduce onboarding time and operational complexity for end users. Fifth, engage proactively with regulatory and standards bodies to influence test methodologies and to ensure that new products align with evolving requirements. Finally, adopt measurable sustainability practices across material sourcing and packaging to meet increasing procurement expectations and to reduce lifecycle environmental impacts.

Transparent and rigorous research methodology describing primary interviews technical validation literature synthesis expert review and triangulation techniques used to ensure reliability and relevance

The research methodology underpinning this analysis combines qualitative and technical approaches to ensure rigor and relevance. Primary evidence comes from structured interviews with clinicians, procurement officers, engineering leads, and materials scientists, which provide contextual understanding of performance expectations and operational constraints. Secondary sources include peer-reviewed literature, standards documentation, and technical white papers that illuminate validation practices and material performance characteristics.

Technical validation involved laboratory evaluations and supplier capability assessments to verify claims about material stability, dimensional accuracy, and modality compatibility. Triangulation across data streams-interviews, technical tests, and literature-supported robust interpretation of trends and reduced single-source bias. Throughout the process, expert panels reviewed draft findings to ensure practical relevance and to highlight areas requiring further investigation. The methodology acknowledges limitations inherent to fast-evolving technologies and recommends periodic reassessment to capture rapid innovation cycles.

Concise concluding synthesis stressing the imperative for integrated investment in materials validation supply chain resilience regulatory alignment and clinical partnerships

In conclusion, the medical imaging phantom sector stands at an inflection point where materials innovation, manufacturing agility, and service-led differentiation determine strategic outcomes. Phantoms increasingly serve as critical enablers for device validation, clinical training, and algorithmic performance assessment, and stakeholders that align product design with modality-specific needs and end-user workflows realize greater adoption. Supply chain resilience and regulatory alignment complement technical excellence, forming the operational foundation necessary for scale.

Decision-makers should therefore focus on integrated strategies that combine technical innovation with robust validation, responsive supply chain design, and strong clinical partnerships. By doing so, organizations can not only manage near-term disruptions but also position themselves to capture the long-term value that accrues to solutions demonstrating repeatable performance, regulatory readiness, and clear operational benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Phantoms Market, by Product Type

  • 8.1. CT Phantom
  • 8.2. MRI Phantom
  • 8.3. Nuclear Imaging Phantom
  • 8.4. Pet Phantom
  • 8.5. Ultrasound Phantom
  • 8.6. X-Ray Phantom

9. Medical Imaging Phantoms Market, by Material

  • 9.1. Acrylic
  • 9.2. Epoxy
  • 9.3. Hydrogel
  • 9.4. Plastic
  • 9.5. Rubber

10. Medical Imaging Phantoms Market, by Application

  • 10.1. Equipment Testing
  • 10.2. Quality Assurance
  • 10.3. Research
  • 10.4. Training & Education

11. Medical Imaging Phantoms Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Pharmaceutical Companies

12. Medical Imaging Phantoms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Imaging Phantoms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Imaging Phantoms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Imaging Phantoms Market

16. China Medical Imaging Phantoms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BARTEC Top Holding GmbH
  • 17.6. Biodex Medical Systems, Inc.
  • 17.7. Carville Limited
  • 17.8. Computerized Imaging Reference Systems (CIRS), Inc.
  • 17.9. Dielectric Corporation
  • 17.10. Gammex, Inc.
  • 17.11. Gold Standard Phantoms
  • 17.12. Kyoto Kagaku Co., Ltd.
  • 17.13. Leeds Test Objects Ltd.
  • 17.14. Modus Medical Devices Inc.
  • 17.15. PTW Freiburg GmbH
  • 17.16. Pure Imaging Phantoms
  • 17.17. QUART GmbH
  • 17.18. The Phantom Laboratory, Inc.
  • 17.19. True Phantom Solutions

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)